These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 18508414

  • 1. Uptake of oleoyl-chitosan nanoparticles by A549 cells.
    Zhang J, Chen XG, Peng WB, Liu CS.
    Nanomedicine; 2008 Sep; 4(3):208-14. PubMed ID: 18508414
    [Abstract] [Full Text] [Related]

  • 2. [Study of the uptake of chitosan oligosaccharide nanoparticles by A549 cells].
    Wan LQ, Hu FQ, Yuan H.
    Yao Xue Xue Bao; 2004 Mar; 39(3):227-31. PubMed ID: 15171662
    [Abstract] [Full Text] [Related]

  • 3. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
    Zhang J, Chen XG, Li YY, Liu CS.
    Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
    [Abstract] [Full Text] [Related]

  • 4. Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies.
    Zheng Y, Cai Z, Song X, Chen Q, Bi Y, Li Y, Hou S.
    J Drug Target; 2009 May; 17(4):294-303. PubMed ID: 19255895
    [Abstract] [Full Text] [Related]

  • 5. Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin.
    Zhang J, Chen XG, Sun GZ, Huang L, Cheng XJ.
    Colloids Surf B Biointerfaces; 2010 Jun 01; 77(2):125-30. PubMed ID: 20172698
    [Abstract] [Full Text] [Related]

  • 6. Preparation and characterization of lectin-conjugated chitosan fluorescent nanoparticles.
    Liu J, Zhang L, Wang C, Xu H, Zhao X.
    Mol Biosyst; 2010 Jun 01; 6(6):954-7. PubMed ID: 20379582
    [Abstract] [Full Text] [Related]

  • 7. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release.
    Park JS, Han TH, Lee KY, Han SS, Hwang JJ, Moon DH, Kim SY, Cho YW.
    J Control Release; 2006 Sep 28; 115(1):37-45. PubMed ID: 16935380
    [Abstract] [Full Text] [Related]

  • 8. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B, Somavarapu S, Li XW, Thanou M, Sesardic D, Alpar HO, Senel S.
    Int J Pharm; 2008 Nov 03; 363(1-2):139-48. PubMed ID: 18662762
    [Abstract] [Full Text] [Related]

  • 9. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
    Mandal BB, Kundu SC.
    Nanotechnology; 2009 Sep 02; 20(35):355101. PubMed ID: 19671963
    [Abstract] [Full Text] [Related]

  • 10. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
    Lin A, Liu Y, Huang Y, Sun J, Wu Z, Zhang X, Ping Q.
    Int J Pharm; 2008 Jul 09; 359(1-2):247-53. PubMed ID: 18457928
    [Abstract] [Full Text] [Related]

  • 11. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles.
    Nam HY, Kwon SM, Chung H, Lee SY, Kwon SH, Jeon H, Kim Y, Park JH, Kim J, Her S, Oh YK, Kwon IC, Kim K, Jeong SY.
    J Control Release; 2009 May 05; 135(3):259-67. PubMed ID: 19331853
    [Abstract] [Full Text] [Related]

  • 12. [Chitosan nanoparticles as gene vector: effect of particle size on transfection efficiency].
    Yang XR, Zong L, Yuan XY.
    Yao Xue Xue Bao; 2007 Jul 05; 42(7):774-9. PubMed ID: 17882964
    [Abstract] [Full Text] [Related]

  • 13. Plasmid size influences chitosan nanoparticle mediated gene transfer to chondrocytes.
    Xu X, Capito RM, Spector M.
    J Biomed Mater Res A; 2008 Mar 15; 84(4):1038-48. PubMed ID: 17685397
    [Abstract] [Full Text] [Related]

  • 14. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.
    Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y.
    Int J Pharm; 2009 Dec 01; 382(1-2):198-204. PubMed ID: 19646519
    [Abstract] [Full Text] [Related]

  • 15. [Preparation and characterization of biotinylated chitosan nanoparticles].
    Yao Q, Hou SX, Zhang X, Zhao G, Gou XJ, You JZ.
    Yao Xue Xue Bao; 2007 May 01; 42(5):557-61. PubMed ID: 17703783
    [Abstract] [Full Text] [Related]

  • 16. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
    Liu X, Howard KA, Dong M, Andersen MØ, Rahbek UL, Johnsen MG, Hansen OC, Besenbacher F, Kjems J.
    Biomaterials; 2007 Feb 01; 28(6):1280-8. PubMed ID: 17126901
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
    Bilensoy E, Sarisozen C, Esendağli G, Doğan AL, Aktaş Y, Sen M, Mungan NA.
    Int J Pharm; 2009 Apr 17; 371(1-2):170-6. PubMed ID: 19135514
    [Abstract] [Full Text] [Related]

  • 19. Subcellular compartment targeting of layered double hydroxide nanoparticles.
    Xu ZP, Niebert M, Porazik K, Walker TL, Cooper HM, Middelberg AP, Gray PP, Bartlett PF, Lu GQ.
    J Control Release; 2008 Aug 25; 130(1):86-94. PubMed ID: 18614254
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery.
    Chen F, Zhang ZR, Yuan F, Qin X, Wang M, Huang Y.
    Int J Pharm; 2008 Feb 12; 349(1-2):226-33. PubMed ID: 17825506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.